Title:
AZOLE COMPOUNDS
Document Type and Number:
WIPO Patent Application WO/2003/072554
Kind Code:
A1
Abstract:
Compounds represented by the general formula (I) or salts thereof which are useful in the prevention or treatment of diabetic neuropathy and so on: (I) wherein R1 is hydrogen, halogeno, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, optionally substituted hydroxyl, optionally substituted mercapto, or optionally substituted amino; A is optionally substituted cycloamino or -NR2-W-D (wherein R2 is hydrogen or alkyl; W is a free valency or a divalent acyclic hydrocarbon group; and D is an optionally substituted cyclic group, optionally substituted amino, or optionally substituted acyl); B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X is oxygen, sulfur, or optionally substituted nitrogen; and Y is a free valency and a divalent acyclic hydrocarbon group.
More Like This:
Inventors:
SAKAI NOZOMU (JP)
MOMOSE YU (JP)
MURASE KATSUHITO (JP)
HAZAMA MASATOSHI (JP)
MOMOSE YU (JP)
MURASE KATSUHITO (JP)
HAZAMA MASATOSHI (JP)
Application Number:
PCT/JP2003/002217
Publication Date:
September 04, 2003
Filing Date:
February 27, 2003
Export Citation:
Assignee:
TAKEDA CHEMICAL INDUSTRIES LTD (JP)
SAKAI NOZOMU (JP)
MOMOSE YU (JP)
MURASE KATSUHITO (JP)
HAZAMA MASATOSHI (JP)
SAKAI NOZOMU (JP)
MOMOSE YU (JP)
MURASE KATSUHITO (JP)
HAZAMA MASATOSHI (JP)
International Classes:
A61P3/10; A61P25/00; A61P25/24; A61P43/00; C07D263/32; C07D263/38; C07D263/46; C07D263/48; C07D277/28; C07D277/30; C07D277/40; C07D277/46; C07D413/04; C07D413/06; C07D413/12; C07D413/14; C07D417/04; C07D417/14; C07F9/653; C07F9/6539; (IPC1-7): C07D263/32; C07D263/46; C07D263/48; C07D277/28; C07D413/04; C07D413/12; C07D413/14; C07D417/12; C07D417/14; C07D405/12; C07D417/04; C07D413/06; C07F9/6506; C07F9/653; C07F9/6539; C07F9/6558; C07F9/6561; A61K31/421; A61K31/422; A61K31/426; A61K31/427; A61K31/433; A61K31/4439; A61K31/454; A61K31/496; A61K31/506; A61K31/5377; A61K31/541; A61K31/554; A61K31/675; A61K31/4545; A61K31/4709; A61P3/10; A61P25/00; A61P25/24; A61P43/00
Domestic Patent References:
WO1999002505A1 | 1999-01-21 | |||
WO2001077101A1 | 2001-10-18 | |||
WO2001010866A1 | 2001-02-15 | |||
WO2002020484A1 | 2002-03-14 | |||
WO1997036882A1 | 1997-10-09 |
Foreign References:
GB1425505A | 1976-02-18 | |||
EP0987265A1 | 2000-03-22 | |||
EP0526877A2 | 1993-02-10 | |||
JPS4614458B1 | 1971-04-17 | |||
JPS5283747A | 1977-07-12 |
Other References:
BENGTSSON STEFAN ET AL.: "Compounds related to clomethiazole VI. Synthesis of some reference compounds in connection with biotransformation studies", ACTA PHARM. SUEC., vol. 19, no. 1, 1982, pages 37 - 42, XP002968828
TADEUSZ JAKOBIEC ET AL.: "Synthesis of derivatives of 2-amino-4-P-chlorophenylthiazole-5-acetic acid", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, vol. 26, no. 1-6, 1978, pages 935 - 941, XP002968829
TADEUSZ JAKOBIEC ET AL.: "Synthesis of derivatives of 2-amino-4-P-chlorophenylthiazole-5-acetic acid", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, vol. 26, no. 1-6, 1978, pages 935 - 941, XP002968829
Attorney, Agent or Firm:
Takahashi, Shuichi c/o Osaka Plant of TAKEDA CHEMICAL INDUSTRIES LTD. (17-85, Jusohonmachi 2-chome, Yodogawa-k, Osaka-shi Osaka, JP)
Download PDF: